Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 232 results for "mirati"

Mirati Therapeutics  Release: Pharma Announces Closing Of Public Offering Of Common Stock And Full Exercise Of Underwriter's Option To Purchase Additional Shares

MIRATI THERAPEUTICS : Provides Update On Glesatinib And Sitrav...

By a News Reporter-Staff News Editor at Clinical Trials Week -- - Mirati Therapeutics, Inc. (Mirati or the Company) (NASDAQ: MRTX) announced data from two ongoing clinical programs, including the Phase 1b and Phase 2 trials of glesatinib, a spectrum ... 4 Traders, 1 week ago

27 images for mirati

American Banking News, 20 hours ago
PharmaVOICE, 1 week ago
WKRB News, 1 week ago
Analyst, 1 week ago
BioSpace, 1 week ago
American Banking News, 3 weeks ago
Financial Express, 1 month ago, 1 month ago
Nasdaq, 1 month ago
American Banking News, 2 months ago

At President village too, bank busier than ever

MIRATI (BIRBHUM): Five to six customers used to frequent UBI's Mirati branch — in President Pranab Mukherjee's ancestral village — a day till things started changing after demonetisation. A total Rs 1.5 crore has been deposited in the last month ...
 Times of India4 weeks ago Mamata greets President on his birthday  NetIndia123.com1 month ago Sonia Gandhi wishes Pranab Mukherjee on his 81st birthday today  India.com1 month ago Lata Mangeshkar wishes Prez on birthday  Press Trust of India1 month ago

BRIEF-Broadfin Capital LLC reports 6.90 pct passive stake in Mirati Therapeutics Inc as of Jan 6, 2017

n"Jan 9 Broadfin Capital LLC: * Broadfin Capital LLC reports 6.90 percent passive stake in Mirati Therapeutics Inc as of January 6, 2017 - Sec Filing Source text ( Further
 Reuters UK1 week ago
American Banking News

Mirati Therapeutics Inc. (MRTX) Major Shareholder Ltd. Braslyn Acquires 61,158 Shares

Mirati Therapeutics Inc. (NASDAQ:MRTX) major shareholder Ltd. Braslyn purchased 61,158 shares of the business's stock in a transaction on Friday, January 20th. The stock was bought at an average cost of $5.46 per share, with a total value of ...
 American Banking News20 hours ago Mirati Therapeutics, Inc. (MRTX) Major Shareholder Acquires $659,378.50 in Stock  American Banking News3 days ago 227,657 Shares in Mirati Therapeutics Inc. (MRTX) Acquired by Great Point Partners LLC  Mideast Time1 day ago 10% Owner of Mirati Therapeutics (NASDAQ:MRTX), Braslyn Ltd., buys 49,776 shares worth $273,768  Empowered News4 days ago

MRTX Prices Offering At $5.60/Share

(RTTNews) - Mirati Therapeutics Inc. (MRTX) has offered to sell 4.35 million shares of its common stock to the public at a price of $5.60 each. The gross proceeds from the offering are expected to be about $65.0 million, and is scheduled to close ...
 Quotenet.com1 week ago Mirati readies equity offering; shares ease 8% after hours  Seeking Alpha2 weeks ago Mirati prices equity offering; shares ease 3% premarket  Seeking Alpha2 weeks ago

Mirati Therapeutics Inc concludes public offering at USD5.60 per share

(M2 EQUITYBITES via COMTEX) -- Biopharmaceutical company Mirati Therapeutics Inc (MRTX) disclosed on Wednesday that it has closed a public offering of 5,002,702 shares of its common stock at USD5.60 per share. This public offering includes the ...
 TradingCharts.com1 week ago MIRATI THERAPEUTICS, INC. : Results of Operations and Financial Condition, Other Events (form 8-K)  4 Traders2 weeks ago

Mirati Therapeutics, Inc. (NASDAQ:MRTX) Average Rating At 3.67

If you are looking for what methodology Alpha One applies to reach stock sentiment, then know that it is algorithm based analytics. It establishes stock sentiment by reviewing news published on different wired channels on a firm. They contemplate on ...
 Markets Daily1 week ago Average Rating Of Mirati Therapeutics, Inc. (NASDAQ:MRTX) At 3.6  Markets Daily1 month ago What Is The Impact Score Of Mirati Therapeutics, Inc. (NASDAQ:MRTX)?  Markets Daily2 months ago
American Banking News

Jefferies Group Reiterates Hold Rating for Mirati Therapeutics, Inc. (MRTX)

Mirati Therapeutics, Inc. (NASDAQ:MRTX)s stock had its hold rating restated by analysts at Jefferies Group in a research note issued on Monday. They currently have a $5.00 price objective on the stock. Jefferies Group's price objective indicates a ...
 American Banking News1 week ago Mirati Therapeutics Receives a Hold from Jefferies  Analyst Ratings.com1 week ago

Commit To Buy Mirati Therapeutics At $5, Earn 30.2% Annualized Using Options

Investors eyeing a purchase of Mirati Therapeutics Inc (MRTX) stock, but tentative about paying the going market price of $5.50/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting ...
 Minyanville1 week ago
[x] Daily Round Up 1/17/17: WPX, MRTI, OPK

Summary Tables of the top insider purchases and sales filed with the SEC on 1/17/17, based on dollar value. Dollar values often do not equate with significance when it comes to insider trades. Proprietary Insider Company Ratings are relayed ...
 Seeking Alpha3 days ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less